Log in to save to my catalogue

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_de3ebfc8fd634078865f3b7040816cf0

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

About this item

Full title

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2022-11, Vol.13 (11), p.974-14, Article 974

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

TP53
, a crucial tumor suppressor gene, is the most commonly mutated gene in human cancers. Aside from losing its tumor suppressor function, mutant p53 (mutp53) often acquires inherent, novel oncogenic functions, which is termed “gain-of-function”. Emerging evidence suggests that mutp53 is highly associated with advanced malignancies and poor pr...

Alternative Titles

Full title

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_de3ebfc8fd634078865f3b7040816cf0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_de3ebfc8fd634078865f3b7040816cf0

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-022-05408-1

How to access this item